Close

Risk of cholera epidemics estimated with new ‘rule-book’

Cholera has repeatedly traveled out of Asia to cause epidemics in Africa and Latin America, according to two new studies published in the journal Science. The research analysed cholera samples from across the globe and revealed information about risk of strains causing an epidemic and their evolution of antibiotic resistance.
Photo | Prevent Cholera leaflet on noticeboard (c) Dr Sandra Moore

The team, which included Nick Thomson, Professor of Bacterial Genomics and Evolution at the London School of Hygiene & Tropical Medicine, researchers from the Wellcome Trust Sanger Institute, Institut Pasteur in France, and collaborators from across the world, studied outbreaks in Africa, Latin America and the Caribbean from the last 60 years.

The authors examined historical cholera samples from across the globe and studied genetic data from over 1200 cholera samples, some dating back to the 1950s. The results present a new ‘rule-book’ to estimate the risk of different cholera strains causing an epidemic.

Professor Nick Thomson, who has a dual appointment at the Wellcome Trust Sanger Institute, said: “These findings have implications for the control of cholera pandemics. We are now getting a real sense of how cholera is moving across the globe, and with that information we can inform improved control strategies as well as basic science to better understand how a simple bacterium continues to pose such a threat to human health.”

The team focused on Africa and Latin America due to the large epidemics that have occurred in those regions. The seventh pandemic of cholera first came to Africa in 1970, and Africa has since become the continent most affected by the disease. Cholera appeared in Latin America in 1991, after an absence of 100 years

Despite being thought of as an ancient disease, cholera still affects 47 countries world-wide and claims the lives of nearly 100 thousand people a year. Since the 1800s, there have been seven cholera pandemics around the globe, resulting in millions of deaths. The current and ongoing pandemic, which began in the 1960s, is caused by a single lineage of Vibrio cholerae, called 7PET.

The largest epidemic in history is ongoing in Yemen, with the total number of cases quickly approaching one million, and the WHO recently announcing a campaign to stop cholera by 2030. The team found that 7PET strains from Asia were repeatedly introduced into two main regions of Africa: West Africa and East/Southern Africa.

François-Xavier Weill, first author on the African study and principal investigator from the Institut Pasteur, said: “Our results show that multiple new versions of 7PET bacteria have entered Africa since the 1970s. Once introduced, cholera outbreaks follow similar paths when spreading across that continent. The results give us a sense of where we can target specific regions of Africa for improved surveillance and control.”

Scientists also investigated the evolution of antibiotic resistance in cholera. The team found that all recent introductions of cholera bacteria into Africa were already resistant to antibiotics. Using the genomic data they were able to track the source of the antibiotic resistance back to South Asia.

In Latin America, the team not only focused on the 7PET strains that cause epidemics, but other strains of Vibrio cholerae that cause sporadic low level disease. This allowed the researchers to uncover that different strains of Vibrio cholerae can be assigned different risks for causing large outbreaks. This has significant implications for cholera control efforts worldwide

Publications

Daryl Domman, Marie-Laure Quilici, Matthew J. Dorman, Elisabeth Njamkepo, Ankur Mutreja, Alison E. Mather, Gabriella Delgado, Rosario Morales-Espinosa, Patrick A. D. Grimont, Marcial Leonardo Lizárraga-Partida, Christiane Bouchier, David M. Aanensen, Pablo Kuri-Morales, Cheryl L. Tarr, Gordon Dougan, Julian Parkhill, Josefina Campos, Alejandro Cravioto, François-Xavier Weill, Nicholas R. Thomson. Integrated view of Vibrio cholerae in the Americas. Science. DOI: 10.1126/science.aao2136

François-Xavier Weill, Daryl Domman, Elisabeth Njamkepo, Cheryl Tarr, Jean Rauzier, Nizar Fawal, Karen H. Keddy, Henrik Salje, Sandra Moore, Asish K. Mukhopadhyay, Raymond Bercion, Francisco J. Luquero, Antoinette Ngandjio, Mireille Dosso, Elena Monakhova, Benoit Garin, Christiane Bouchier, Carlo Pazzani, Ankur Mutreja, Roland Grunow, Fati Sidikou, Laurence Bonte, Sébastien Breurec, Maria Damian, Berthe-Marie Njanpop-Lafourcade, Guillaume Sapriel, Anne-Laure Page, Monzer Hamze, Myriam Henkens, Goutam Chowdhury, Martin Mengel, Jean-Louis Koeck, Jean-Michel Fournier, Gordon Dougan, Patrick A. D. Grimont, Julian Parkhill, Kathryn E. Holt, Renaud Piarroux, Thandavarayan Ramamurthy, Marie-Laure Quilici, Nicholas R. Thomson. Genomic history of the seventh pandemic of cholera in Africa. Science. DOI: 10.1126/science.aad5901

Fee discounts

Our postgraduate taught courses provide health practitioners, clinicians, policy-makers, scientists and recent graduates with a world-class qualification in public and global health.

If you are coming to LSHTM to study an intensive master's degree or distance learning programme (PG Cert, PG Dip, MSc or individual modules) starting in 2024, you may be eligible for a 5% discount on your tuition fees.

These fee reduction schemes are available for a limited time only.